Skip to content

Clinical trials

Phase 1/2 Carcinoma, Non-Small-Cell Lung trials in Thailand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Country / region: Thailand Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20151
20181
20211
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
AVEO Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1
RAPT Therapeutics, Inc., a member of the GSK plc group of companies1
Voronoi, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung6
Breast Neoplasms1
Carcinoma1
Carcinoma, Transitional Cell1
Lung Diseases1
Lung Neoplasms1
Lymphoma1
Melanoma1
Nasopharyngeal Carcinoma1
Neoplasm Metastasis1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.